These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 3825161)
1. [Antithrombin III, the most important inhibitor of hemostasis. Physiology and clinical aspects]. Neubauer M; Ramschak H; Lanzer G Wien Med Wochenschr; 1986 Nov; 136(21-22):560-2. PubMed ID: 3825161 [TBL] [Abstract][Full Text] [Related]
2. [Thromboembolism. The clinical significance of antithrombin III]. Schramm W Internist (Berl); 1984 Feb; 25(2):88-92. PubMed ID: 6368458 [No Abstract] [Full Text] [Related]
3. [Antithrombin III and its role in normal and pathological hemostasis]. Bŭchvarova V; Doĭchinov A; Angelova N Vutr Boles; 1981; 20(6):34-8. PubMed ID: 7039127 [TBL] [Abstract][Full Text] [Related]
4. Antithrombin III deficiency: clinical aspects. Nagy I Haematologia (Budap); 1984; 17(1):87-91. PubMed ID: 6724356 [TBL] [Abstract][Full Text] [Related]
5. Role of antithrombin III as a regulator of in vivo coagulation. Bauer KA; Rosenberg RD Semin Hematol; 1991 Jan; 28(1):10-8. PubMed ID: 2017686 [No Abstract] [Full Text] [Related]
6. [Acquired antithrombin III deficiency]. Müller G Z Gesamte Inn Med; 1992 Feb; 47(2):74-7. PubMed ID: 1585693 [TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic aspects of antithrombin III deficiency. Halal F; Quenneville G; Laurin S; Loulou G Am J Med Genet; 1983 Apr; 14(4):737-50. PubMed ID: 6846404 [No Abstract] [Full Text] [Related]
8. Antithrombin III concentrates--are they clinically useful? Lechner K; Kyrle PA Thromb Haemost; 1995 Mar; 73(3):340-8. PubMed ID: 7667814 [TBL] [Abstract][Full Text] [Related]
9. [Familial thromboembolic disease associated with antithrombin III deficiency (author's transl)]. Bentata-Pessayre M; Aurousseau MH; Josso F; Delzant G Ann Med Interne (Paris); 1980; 131(6):378-82. PubMed ID: 7469244 [TBL] [Abstract][Full Text] [Related]
10. Replacement therapy in patients with hereditary antithrombin III deficiency. Menache D Semin Hematol; 1991 Jan; 28(1):31-8. PubMed ID: 2017690 [No Abstract] [Full Text] [Related]
12. Congenital deficiencies of anticoagulant proteins (antithrombin III and protein C). Mannucci PM; Tripodi A; Mari D Haematologica; 1984; 69(6):730-46. PubMed ID: 6441751 [No Abstract] [Full Text] [Related]
13. The prevalence of hereditary antithrombin-III deficiency in patients with a history of venous thromboembolism. Vikydal R; Korninger C; Kyrle PA; Niessner H; Pabinger I; Thaler E; Lechner K Thromb Haemost; 1985 Dec; 54(4):744-5. PubMed ID: 4089808 [TBL] [Abstract][Full Text] [Related]
14. [Experiences with the substitution of antithrombin III concentrates in congenital and acquired deficiency disorders]. Schramm W Behring Inst Mitt; 1983 Aug; (73):66-78. PubMed ID: 6332613 [TBL] [Abstract][Full Text] [Related]
15. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update. Rodgers GM Thromb Haemost; 2009 May; 101(5):806-12. PubMed ID: 19404531 [TBL] [Abstract][Full Text] [Related]
17. The role of natural coagulation inhibitors in hemostasis. Brandt JT Clin Lab Med; 1984 Jun; 4(2):245-84. PubMed ID: 6094091 [TBL] [Abstract][Full Text] [Related]
18. Antithrombin and its inherited deficiency states. van Boven HH; Lane DA Semin Hematol; 1997 Jul; 34(3):188-204. PubMed ID: 9241705 [TBL] [Abstract][Full Text] [Related]
19. [Congenital antithrombin III deficiency. Use of concentrates in the prevention of thromboembolic episodes]. Velasco F; Andrés P; Torres A Med Clin (Barc); 1985 Oct; 85(10):429. PubMed ID: 4079498 [No Abstract] [Full Text] [Related]